Murphy & Mullick Capital Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Murphy & Mullick Capital Management’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.7K	Hold	410	–	–	0.01%	440
2025 Q4	$14.3K	Hold	410	–	–	0.01%	447
2025 Q3	$16.5K	Hold	410	–	–	0.01%	414
2025 Q2	$13.3K	Hold	410	–	–	0.01%	420
2025 Q1	$11.1K	Hold	410	–	–	0.01%	426
2024 Q4	$11.8K	Buy	+410	New	+$11.9K	0.01%	414

Other funds holding FFTY

CPA

Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CFP

Comprehensive Financial Planning East Petersburg, Pennsylvania $144M AUM 25.61% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DSCM

Del-Sette Capital Management Schenectady, New York $167M AUM 38.06% 1-Year Est. Return

Murphy & Mullick Capital Management's FFTY Position: Q1 2026 in Review

Murphy & Mullick Capital Management held its CapForce IBD 50 ETF (FFTY) position steady in Q1 2026 at 410 shares worth $13.7K. The position accounts for 0.01% of the portfolio, ranked #440.

Murphy & Mullick Capital Management first reported a position in FFTY in Q4 2024 and has held it in 6 quarters since. The position peaked at $16.5K in Q3 2025. 39 funds tracked by Wall St. Rank hold FFTY as of Q1 2026.

Murphy & Mullick Capital Management held 410 shares of CapForce IBD 50 ETF worth $13.7K as of Q1 2026.
Murphy & Mullick Capital Management left its CapForce IBD 50 ETF share count unchanged in Q1 2026.
CapForce IBD 50 ETF made up 0.01% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #440 holding.
Murphy & Mullick Capital Management first reported a position in CapForce IBD 50 ETF in Q4 2024 and has held it in 6 quarters since.
Murphy & Mullick Capital Management's CapForce IBD 50 ETF position peaked at $16.5K in Q3 2025.
39 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.